Basel Medical Group Ltd - BMGL
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| XTX Topco Ltd | History | No change | 25,756 | 15 | 0.0% | 0.0% | 1 | 0 | 0.0% | Q1 2026 | May 15, 2026 |
| T3 Companies, LLC | History | No change | 15,000 | 8 | 0.01% | 0.01% | 2 | 0 | 0.0% | Q1 2026 | May 07, 2026 |
| UBS Group AG | History | No change | 13,056 | 7 | 0.0% | 0.0% | 3 | 0 | 0.0% | Q1 2026 | May 05, 2026 |
| Polaris Financial Partners | History | New | 1 | 1 | 0.0% | — | 4 | +1 | New | Q3 2026 | Oct 02, 2026 |
| Coston, McIsaac & Partners | History | No change | 50 | 0 | — | — | — | 0 | 0.0% | Q1 2026 | Apr 22, 2026 |